Avian influenza heterologous prime-boost vaccination strategies. Michel BUBLOT Boehringer Ingelheim AH R&D (France)

VETERINARY RESEARCH. Alexandra Richard-Mazet 1, Sylvain Goutebroze 1, François-Xavier Le Gros 1, David E Swayne 2 and Michel Bublot 1*

Richard-Mazet et al. Veterinary Research, : VETERINARY RESEARCH RESEARCH Open Access Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule

Vaccines of today and products needed for the short-, intermediate- and longterm. OIE/FAO OFFLU Conference Beijing China December 4-6, 2013

Vaccines of today and products needed for the short-, intermediate- and longterm XU, Wei-Cheng OIE/FAO OFFLU Conference Beijing China December 4-6, 2013 1 Influenza A reservoir & transmission H3N8, (H5N1)

YOU THINK INFLUENZA IS FATAL? THINK AGAIN.

YOU THINK INFLUENZA IS FATAL? THINK AGAIN. HVT vector vaccine for H5 Avian Influenza protection Avian influenza Avian influenza remains a major threat for the global poultry industry. Among the different

Press Pack. Ceva launches VECTORMUNE AI, a novel technology vaccine for H5 Avian Influenza protection

Press Pack Ceva launches VECTORMUNE AI, a novel technology vaccine for H5 Avian Influenza protection Content 1) Summary 2) Definition of the vaccine 3) Safety 4) Efficacy 5) Additional advantages 6) Vectormune

Implications and implementation of dayold chick vaccination

Implications and implementation of dayold chick vaccination FAO technical meeting Beijing, 3 December 2013 Sophie von Dobschuetz On behalf of the meeting participants 1 Meeting background and objectives

Investigation on the possible application of a serological DIVA monitoring strategy when a rhvt-h5 vaccine is used to control Avian Influenza

AVMA AAAP Convention 2016 August 7, San Antonio, Texas, USA Investigation on the possible application of a serological DIVA monitoring strategy when a rhvt-h5 vaccine is used to control Avian Influenza

SEPRL NC1180 Station Report

SEPRL NC1180 Station Report Project: Control of emerging and re-emerging poultry respiratory diseases in the united states Avian influenza group: David E. Swayne, David L. Suarez, Darrell R. Kapczynski,

Immunogenicity of Poxvirus Vector Avian Influenza Vaccines in Muscovy and Pekin Ducks

AVIAN DISEASES 54:232 238, 2010 Research Note Immunogenicity of Poxvirus Vector Avian Influenza Vaccines in Muscovy and Pekin Ducks Michel Bublot, AE Alexandra Richard-Mazet, A Sandrine Chanavat-Bizzini,

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION 1. SUMMARY OF THE DOSSIER Nobilis Influenza H5N2 emulsion for injection, is an adjuvanted, inactivated vaccine against avian influenza type A, subtype H5 in chickens. Avian influenza

Clinical Trials of Pandemic Vaccines: Key Issues. John Treanor University of Rochester Rochester, NY

Clinical Trials of Pandemic Vaccines: Key Issues John Treanor University of Rochester Rochester, NY Inactivated vaccine approach Proven technology Used successfully in 1957 and 1968 Abundant efficacy data

The development of avian influenza vaccines for emergency use

11 The development of avian influenza vaccines for emergency use T.R. Mickle, D.E. Swayne, and N. Pritchard Abstract Costly outbreaks of mildly and highly pathogenic avian influenza (AI) have occurred

Graduated from Kyoto University, Graduate School of Agriculture, Japan M.S degree on Molecular Biology and Microbiology.

Dr.Moto Esaki Senior Chief Reseacher Ceva Japan K.K Graduated from Kyoto University, Graduate School of Agriculture, Japan M.S degree on Molecular Biology and Microbiology. 1999 : Joined Biology department

Introduction to Avian Influenza

Introduction to Avian Influenza David L. Suarez D.V.M., Ph.D. Research Leader Exotic and Emerging Avian Viral Disease Research Unit Agricultural Research Service United States Department of Agriculture

Vaccination to stop transmission

Vaccination to stop transmission Arjan Stegeman j.a.stegeman@uu.nl Faculty of Veterinary Medicine Goals of vaccination To prevent clinical disease (production, animal welfare, treatment costs, antimicrobial

RECOMBINANT VACCINES Live or Killed

Antigens and Vaccines Molecular biology drives Innovation Antigen Gene of Interest Recombination RECOMBINANT VACCINES Live or Killed Antigens and Vaccines Molecular biology drives Innovation Antigen Gene

http://www.ibs.upm.edu.my Challenges in controlling viral diseases of poultry Abdul Rahman Omar Institute of Bioscience Faculty of Veterinary Medicine Universiti Putra Malaysia aro@upm.edu.my Outline of

The Influence of Different Challenge Doses of Highly Pathogenic Avian Influenza on the Efficacy of Different Avian Influenza Vaccine

American Journal of Microbiology and Biotechnology 2016; 3(3): 18-22 http://www.aascit.org/journal/ajmb ISSN: 2375-3005 The Influence of Different Challenge Doses of Highly Pathogenic Avian Influenza on

Advances in Marek s Disease Vaccine Development:

Advances in Marek s Disease Vaccine Development: Michel Bublot, DVM, PhD - Merial R&D Asian Avian Forum 2016, Tokyo, July 12-13 Marek s Disease Control Good flock management Cleaning, disinfection Adequate

Rapid and Accuracy Diagnosis of Highly Pathogenic Avian Influenza (H5N8) Virus used for the Control of the Outbreak in the Republic of Korea

Rapid and Accuracy Diagnosis of Highly Pathogenic Avian Influenza (H5N8) Virus used for the Control of the Outbreak in the Republic of Korea Third Global Conference of OIE Reference Centres Incheon(Seoul),

Vaccine and Disease Research Responses to the HPAIV Outbreaks SEPRL Avian Influenza Research Team David L. Suarez

Vaccine and Disease Research Responses to the 2015-2016 HPAIV Outbreaks SEPRL Avian Influenza Research Team David L. Suarez Southeast Poultry Research Laboratory U.S. National Poultry Research Center,

ESSENTIAL PROTECTION

ESSENTIAL PROTECTION for better life BROILER ND K VITABRON L VITAPEST L NEW L Supported by C H I C K P R O G R A M CONVENTIONAL vaccine range against Newcastle Disease CEVA HATCHERY I MMUNIZATION CONTROL

David L. Suarez D.V.M., PhD. A.C.V.M.

David L. Suarez D.V.M., PhD. A.C.V.M. Southeast Poultry Research Laboratory United States National Poultry Research Center The author has no commercial interests in any commercial products presented. U.S.

MG and MS Control in Layers

MG and MS Control in Layers Bernie Beckman, DVM Hy-Line International Hy-Line International Genetic Excellence Respiratory Diseases of Poultry Bacterial Diseases M. gallisepticum M. synoviae Coryza - Avibacterium

Current limitations on the use of vaccination against avian influenza

Current limitations on the use of vaccination against avian influenza Ian Brown Director of EU/OIE/FAO International Reference Laboratory for Avian Influenza, Newcastle Disease and Swine Influenza Animal

REVIEW Cell-mediated Immunity to Influenza Virus Infections: From the Perspective to the Vaccine Development against Highly Pathogenic Avian Influenza

JARQ 42 (4), 245 249 (2008) http://www.jircas.affrc.go.jp REVIEW : From the Perspective to the Vaccine Development against Highly Pathogenic Avian Influenza Hirokazu HIKONO 1 *, Masaji MASE 2, Satoko WATANABE

Principles for event based and active avian influenza surveillance. Les Sims Asia Pacific Veterinary Information Services

Principles for event based and active avian influenza surveillance Les Sims Asia Pacific Veterinary Information Services apvis@bigpond.net.au Introduction No one size fits all surveillance system for avian

Evaluation of a Commercial ELISA Kit (IDEXX) to Differentiate AI Virus-infected Poultry from AI- Vaccinated Poultry (DIVA)

Brazilian Journal of Poultry Science Revista Brasileira de Ciência Avícola ISSN 1516-635X Apr - Jun 2014 / v.16 / n.2 / 73-78 http://dx.doi.org/10.1590/1516-635x160273-78 Author(s) Talazadeh F I Mayahi

Dr.Christophe Cazaban

Dr.Christophe Cazaban Technical Manager Biology Innovation Strategy Department. Ceva Sante Animale, France Graduated from the French Veterinary University of Lyon in 1993 He completed his education with

OIE Regional Workshop on Enhancing Influenza Viruses National Surveillance Systems, Tokyo, August 2014

OIE Regional Workshop on Enhancing Influenza Viruses National Surveillance Systems, Tokyo, 26-28 August 2014 Animal population Birds Million Animal Million Chicken 249 Cattle 23.34 Duck 47.2 Buffalo 1.45

C E E Z A D. Rational Development of Influenza Vaccines: NDV-based influenza vaccines for poultry and livestock

C E E Z A D Center of Excellence for Emerging and Zoonotic Animal Diseases A Department of Homeland Security Center of Excellence Rational Development of Influenza Vaccines: NDV-based influenza vaccines

Advanced Biotechnology in the Development of Novel Vaccines against Major Farm Animal Infectious Diseases in China

Advanced Biotechnology in the Development of Novel Vaccines against Major Farm Animal Infectious Diseases in China Xiufan Liu Animal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou

General context and objectives of the project. Public private partnership (PPP) in Veterinary Public Health. EVADOC project Bangladesh Jan-June 2015

Modeling the effectiveness of avian influenza vaccination strategies in Bangladesh: evaluation of the added value of day old chick vaccination in hatcheries General context and objectives of the project

Laboratory Diagnosis of Avian Influenza and Newcastle Disease

Laboratory Diagnosis of Avian Influenza and Newcastle Disease Dennis A. Senne dennis.a.senne@aphis.usda.gov (515) 239-7551 U. S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary

ISSN: (Print) (Online) Journal homepage:

Avian Pathology ISSN: 0307-9457 (Print) 465-3338 (Online) Journal homepage: http://www.tandfonline.com/loi/cavp20 Protection conferred by recombinant turkey herpesvirus avian influenza (rhvt-h5) vaccine

REVIEW ARTICLE Avian influenza vaccines: a practical review in relation to their application in the field with a focus on the Asian experience

Epidemiol. Infect., Page 1 of 21. doi:10.1017/s0950268808001039 f 2008 Cambridge University Press Printed in the United Kingdom REVIEW ARTICLE Avian influenza vaccines: a practical review in relation to

Potential Role of Exposure to Poultry Products and By-products for Human H5N1 infections

Potential Role of Exposure to Poultry Products and By-products for Human HN infections David E. Swayne, A. Lipatov, Y.K. Kwon, M. Jackwood & J. Beck USDA/Agricultural Research Service Southeast Poultry

Active and Passive Immunization for Avian Influenza Virus Infections

NIAID Active and Passive Immunization for Avian Influenza Virus Infections Kanta Subbarao, MD, MPH Laboratory of Infectious Diseases NIAID, NIH Immortalizing H5 HA-Specific Memory B Cells Collection of

Use of ACIA as a screening test for AI Surveillance

Use of ACIA as a screening test for AI Surveillance Erica Spackman Southeast Poultry Research Laboratory US National Poultry Research Center USDA-Agricultural Research Service Athens, GA Why use ACIA?

Pakistan Veterinary Journal

RESEARCH ARTICLE Pakistan Veterinary Journal ISSN: 0253-8318 (PRINT), 2074-7764 (ONLINE) DOI: 10.29261/pakvetj/2018.112 Estimation of Pathological and Molecular Findings in Vaccinated and Non-Vaccinated

2007 : Became Poultry Corporate Marketing Director. Ceva Sante Animale, France

Dr. Sylvain Comte Poultry Corporate Marketing Director Ceva Sante Animale, France Graduated as a Veterinary in 1993 from National Veterinary School of Nantes France Master of science in Physiology and

H9N2 avian influenza virus in Korea: evolution and vaccination

Review article CLINICAL EXPERIMENTAL VACCINE RESEARCH H9N2 avian influenza virus in Korea: evolution and vaccination Clin Exp Vaccine Res 2013;2:26-33 pissn 2287-3651 eissn 2287-366X Dong-Hun Lee, Chang-Seon

Review on vectored influenza vaccines. Sarah Gilbert Jenner Institute Oxford

Review on vectored influenza vaccines Sarah Gilbert Jenner Institute Oxford Viral Vectored Influenza Vaccines Can be used to induce antibodies against HA Will also boost CD4 + T cell responses against

I N T R O D U C T I O N

I N T R O D U C T I O N Wednesday 5 April 2017 Jérôme BAUDON, Head of Avian Strategic Business Unit Boehringer Ingelheim THE NEW BOEHRINGER INGELHEIM Merial is now part of the Boehringer Ingelheim family.

EFFICACY OF AVIAN INFLUENZA VIRUS LOCALLY MANUFACTURED AND IMPORTED VACCINES ABSTRACT

Shaukat et al., The Journal of Animal & Plant Sciences, 26(3): 2016, Page: J. 653-657 Anim. Plant Sci. 26(3):2016 ISSN: 1018-7081 EFFICACY OF AVIAN INFLUENZA VIRUS LOCALLY MANUFACTURED AND IMPORTED VACCINES

Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention. June 18, 2015 NIBSC

Workshop on Immunoassay Standardization for Universal Flu Vaccines Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention June 18, 2015 NIBSC 1 Multiple Immune Mechanisms Contribute

Control of HPAI by Vaccination: Opportunities and Challenges

Control of HPAI by Vaccination: Opportunities and Challenges Santanu Bandyopadhyay FAO, Vietnam This presentation has been prepared by selectively copying from presentations on related subjects by Experts

Director Biology Innovation Strategy Department. Ceva Sante Animale, France

Dr.Yannick Gardin Director Biology Innovation Strategy Department. Ceva Sante Animale, France Graduated as a Doctor in Veterinary Medicine, from Veterinary School of Lyon France 1977 : Join Ceva as Technical

Agricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA

Agricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA David L. Suarez Southeast Poultry Research Laboratory, Exotic and Emerging Avian Viral Diseases Research

Worldwide perspective on Infectious Bronchitis. Ruth Bouwstra, DVM, PhD Turkey February 2017

Worldwide perspective on Infectious Bronchitis Ruth Bouwstra, DVM, PhD Turkey February 2017 Infectious bronchitis virus Corona Virus, a ssrna virus - Relatively high rate of mutations (0,0012 subst per

Maximising the benefits of Serological Monitoring and Reporting

Maximising the benefits of Serological Monitoring and Reporting AviAfrica, 21-06-2017, Johannesburg Luuk Stooker, DVM Senior Product Manager BioChek Forecast on food Source: Rabobank Forecast on meat consumption

EVALUATION OF SINDBIS-M2E VIRUS VECTOR AS A UNIVERSAL INFLUENZA A VACCINE. A Thesis CHRISTINE NGUYEN VUONG

EVALUATION OF SINDBIS-M2E VIRUS VECTOR AS A UNIVERSAL INFLUENZA A VACCINE A Thesis by CHRISTINE NGUYEN VUONG Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of

The surveillance programme for avian influenza (AI) in poultry in Norway 2017

Annual Report The surveillance programme for avian influenza (AI) in poultry in Norway 2017 Norwegian Veterinary Institute The surveillance programme for avian influenza (AI) in poultry in Norway 2017

Min-Chul Kim, Jun-Gu Choi, Ji-Sun Kwon, Hyun-Mi Kang, Mi-Ra Paek, Ok-Mi Jeong, Jun-Hun Kwon, and Youn-Jeong Lee*

CLINICAL AND VACCINE IMMUNOLOGY, Dec. 2010, p. 1977 1984 Vol. 17, No. 12 1556-6811/10/$12.00 doi:10.1128/cvi.00191-10 Copyright 2010, American Society for Microbiology. All Rights Reserved. Field Application

Field Application of H9M2e-ELISA for Differentiation of H9N2 Avian Influenza-Infected Chickens from Vaccinated Chickens

CVI Accepts, published online ahead of print on 27 October 20 Clin. Vaccine Immunol. doi:.1128/cvi.00191- Copyright 20, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

Ceva s offer to optimize performance Simpler vaccination and better safety

Ceva s offer to optimize performance Simpler vaccination and better safety Rick van Oort Poultry Corporate Range Manager Layer range CEVA Sante Animale Bangkok-Thailand March 12, 2013 Bodyweight (g) 1600

Productivity and Immune Response of Broiler Chickens Vaccinated with Different Avian Influenza Vaccines at One or Seven Days of Age

Australian Journal of Basic and Applied Sciences, 5(10): 325-334, 2011 ISSN 1991-8178 Productivity and Immune Response of Broiler Chickens Vaccinated with Different Avian Influenza Vaccines at One or Seven

David L. Suarez Research Leader EEAV

David L. Suarez Research Leader EEAV Southeast Poultry Research Laboratory United States National Poultry Research Center U.S. National Poultry Research Center Past, ongoing and future research in the

Avian Influenza Vaccination: A Commentary Focusing on H5N1 High Pathogenicity Avian Influenza

University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Other Publications in Zoonotics and Wildlife Disease Wildlife Disease and Zoonotics 2007 Avian Influenza Vaccination: A

INTRODUCTION. J.-H. Roh,,1 M. Kang,,1 B. Wei, R.-H. Yoon, H.-S. Seo, J.-Y. Bahng, J.-T. Kwon, S.-Y. Cha,,1 and H.-K. Jang,2

Efficacy of HVT-IBD vector vaccine compared to attenuated live vaccine using in-ovo vaccination against a Korean very virulent IBDV in commercial broiler chickens J.-H. Roh,,1 M. Kang,,1 B. Wei, R.-H.

THE USE OF VACCINATION AS AN OPTION FOR THE CONTROL OF AVIAN INFLUENZA

71 SG/12/CS3 E Original: English THE USE OF VACCINATION AS AN OPTION FOR THE CONTROL OF AVIAN INFLUENZA Ilaria Capua 1 & Stefano Marangon 2 1 OIE Reference Laboratory and National Reference Laboratory

Universal protection against infectious bursal disease (IBD) induced by the vector vaccine VAXXITEK HVT+IBD

Review Universal protection against infectious bursal disease (IBD) induced by the vector vaccine VAXXITEK HVT+IBD Lemiere S. 1 & Rojo F. 2 1 Merial S.A.S., 29 avenue Tony Garnier 69348 Lyon cedex 07 France

Immunogenicity of Avian Influenza H7N9 Virus in Birds

Immunogenicity of Avian Influenza H7N9 Virus in Birds Identification of Viral Epitopes Recognized by the Immune System Following Vaccination and Challenge Darrell R. Kapczynski US DEPARTMENT OF AGRICULTURE,

David E. Swayne and Joan R. Beck

AVIAN DISEASES 49:81 85, 2005 Experimental Study to Determine if Low-Pathogenicity and High-Pathogenicity Avian Influenza Viruses Can Be Present in Chicken Breast and Thigh Meat Following Intranasal Virus

AVIAN INFLUENZA & NEWCASTLE ACTIVITIES

AVIAN INFLUENZA & NEWCASTLE ACTIVITIES MIA KIM TORCHETTI, DVM MS PHD SECTION HEAD AVIAN, DIAGNOSTIC VIROLOGY LABORATORY U.S. DEPARTMENT OF AGRICULTURE ANIMAL AND PLANT HEALTH INSPECTION SERVICE VETERINARY

The humoral immune responses to IBV proteins.

The humoral immune responses to IBV proteins. E. Dan Heller and Rosa Meir The Hebrew University of Jerusalem, Israel COST FA1207 meeting WG2 + WG3, Budapest, Jan. 2015 1 IBV encodes four major structural

Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong Special Administrative Region, China

CVI Accepts, published online ahead of print on 4 January 2012 Clin. Vaccine Immunol. doi:10.1128/cvi.05358-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Evaluation of

Avian Influenza Summary

Avian Influenza Summary Worldwide distribution Sporadic outbreaks of High Path H5 and H7 in poultry Wild aquatic birds are reservoirs for all avian influenza viruses Viruses can change quickly (mutation)

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 31/05/2018 The epidemiology of avian influenza (AI) is complex. The AI virus constantly evolves by mutation and re-assortment with

Optimization for Chick Performance Bangkok, Thailand 12 th March 2013

Optimization for Chick Performance Bangkok, Thailand 12 th March 2013 Marcelo PANIAGO, DVM, MSc, MBA Director Global Veterinary Services - Poultry Ceva Santé Animale Libourne - France Evolution of the

Avian Influenza/Newcastle Disease Virus Subcommittee

Avian Influenza/Newcastle Disease Virus Subcommittee David L. Suarez D.V.M., Ph.D. Patti Miller D.V.M., Ph.D. Claudio Afonso Ph.D. Southeast Poultry Research Laboratory United States National Poultry Research

Monitoring for Mycoplasma

Monitoring for Mycoplasma in vaccinated and non-vaccinated Poultry flocks Dr. Bart van Leerdam, PhD Prevention and Control Tactics of Mycoplasma spp. in Poultry 1. Maintaining flocks free of Mycoplasma

Antigenic cartography of H5 viruses

14th joint annual meeting of the national reference laboratories for AI and ND Brussels, April 10, 2008 Antigenic cartography of H5 viruses Ron A.M. Fouchier, PhD. Professor Molecular Virology National

Avian influenza and pandemic threats

Avian influenza and pandemic threats Philippe BUCHY MD, PhD Head of Virology Unit Director NIC Cambodia Vaccinology 2013 Bangkok, 11-13 November 2013 Influenza viruses Influenza viruses (Orthomyxoviridae)

Effect of Vaccine Use in the Evolution of Mexican Lineage H5N2 Avian Influenza Virus

JOURNAL OF VIROLOGY, Aug. 2004, p. 8372 8381 Vol. 78, No. 15 0022-538X/04/$08.00 0 DOI: 10.1128/JVI.78.15.8372 8381.2004 Effect of Vaccine Use in the Evolution of Mexican Lineage H5N2 Avian Influenza Virus

Avian Influenza (Bird Flu) Fact Sheet

What is an avian influenza A (H5N1) virus? Influenza A (H5N1) virus also called H5N1 virus is an influenza A virus subtype that occurs mainly in birds. It was first isolated from birds (terns) in South

Avian Influenza and Newcastle Disease: Latest Cases, Epidemiology and Control

Avian Influenza and Newcastle Disease: Latest Cases, Epidemiology and Control David E. Swayne, Claudio Afonso, Patti Miller, David Suarez, & SEPRL Team Exotic & Emerging Avian Viral Diseases Research Unit

Department of Veterinary Pathology, University of Liverpool, Leahurst Campus, Neston, South Wirral, CH64 7TE, UNITED KINGDOM

IMMUNE RESPONSES IN CHICKS AFTER SINGLE OR DUAL VACCINATION WITH LIVE INFECTIOUS BRONCHITIS MASSACHUSETTS AND VARIANT VACCINES: SOME PRELIMINARY FINDINGS GANAPATHY 1 K, ROTHWELL 2 L, LEMIERE 3 S, KAISER

The avian influenza (H7N1) epidemic in Italy: Veterinary and human health implications

Acta Tropica 83 (2002) 7 11 www.parasitology-online.com Review article The 1999 2000 avian influenza (H7N1) epidemic in Italy: Veterinary and human health implications Ilaria Capua a, *, Franco Mutinelli

CENSA-IZSVE: OIE TWINNING PROJECT on AVIAN INFLUENZA and NEWCASTLE DISEASE ( ) Marco De Nardi N. Micoli; MS. Beato; C.

CENSA CENSA-IZSVE: OIE TWINNING PROJECT on AVIAN INFLUENZA and NEWCASTLE DISEASE (2008-2010) 2010) Marco De Nardi N. Micoli; MS. Beato; C. Battisti OIE/FAO Reference Laboratory for Newcastle disease and

24 26 January 2013, Hong Kong SAR, CHINA. TITLE from VIEW and SLIDE MASTER February 27, 2013

The first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses 24 26 January 2013, Hong Kong SAR, CHINA 1 TITLE

Avian Influenza (AI) National & International Update

Avian Influenza (AI) National & International Update T.J. Myers, F. Hegngi, A. Rhorer, P. Klein, T. Duvernoy & M. David USDA, APHIS, Veterinary Services Delmarva Breeder, Hatchery & Grow Out Conference

Feasibility of Production of Human AI Vaccine in AI vaccine Manufacturers in China. Gu Hong Ministry of Agriculture of P. R. China

Feasibility of Production of Human AI Vaccine in AI vaccine Manufacturers in China Gu Hong Ministry of Agriculture of P. R. China AI -- common challenge to the all countries Global cooperation in control

Technical meeting 4-6 December 2013 Beijing

Technical meeting 4-6 December 2013 Beijing Review on cost and financial implications of HPAI vaccination in countries applying HPAI vaccination Jan Hinrichs, Animal Health Economist, FAO Bangkok jan.hinrichs@fao.org

Managing Salmonella Risk. Carl Heeder, DVM

Managing Salmonella Risk Carl Heeder, DVM 1 Overview Levels of Disease Risk Management Disease Risk Equation Flock Immunity Exposure Risk Salmonella Challenge Data Salmonella enteriditis Salmonella heidelberg

Application of Reverse Genetics to Influenza Vaccine Development

NIAID Application of Reverse Genetics to Influenza Vaccine Development Kanta Subbarao Laboratory of Infectious Diseases NIAID, NIH Licensed Vaccines for Influenza Principle: Induction of a protective

Vectormune ND a step towards control of Newcastle Disease

Poultry Vaccinology Summit April 28-30, Budapest, Hungary Vectormune ND a step towards control of Newcastle Disease Yannick Gardin 1, Vilmos Palya 1, John Elattrache 1, Marcelo Paniago 2, Christophe Cazaban

FluSure XP TM Update with Regards to 2009 H1N1 Swine Influenza Virus

FluSure XP TM Update with Regards to 2009 H1N1 Swine Influenza Virus Although the 2009 H1N1 swine influenza virus has not been identified in US swine herds, it should be noted that swine influenza vaccines,

Quantitative evaluation of AI vaccination efficacy for the control of Low Pathogenic Avian Influenza in north-eastern Italy from 2000 to 2006

Chapter 11 Quantitative evaluation of AI vaccination efficacy for the control of Low Pathogenic Avian Influenza in north-eastern Italy from 2000 to 2006 L. Busani, M. Toson, N. Ferrè, M. Dalla Pozza, P.

Review of Avian Influenza A(H5N1) for WHO SAGE

Review of Avian Influenza A(H5N1) for WHO SAGE SAGE Geneva November 2013 Joseph Bresee, MD Epidemiology and Prevention Branch Influenza Division National Center for Immunization and Respiratory Diseases

Event based and active surveillance for avian influenza

Event based and active surveillance for avian influenza Regional Workshop on Enhancing Influenza A viruses National Surveillance Systems Tokyo, Japan August 28-28, 2014 Cristóbal Zepeda MVZ, MSc, PhD International

Characterization and Pathotyping of AIV and APMV-1

Characterization and Pathotyping of AIV and APMV-1 Jan Pedersen, Microbiologist National Veterinary Services Laboratories, Veterinary Services, USDA, Animal Plant Health Inspection Service, Ames, IA Identification

VETERINARY RESEARCH. Costa-Hurtado et al. Veterinary Research (2015) 46:97 DOI /s

Costa-Hurtado et al. Veterinary Research (2015) 46:97 DOI 10.1186/s13567-015-0237-5 VETERINARY RESEARCH RESEARCH ARTICLE Previous infection with virulent strains of Newcastle disease virus reduces highly

Evaluation of the kinetics of anti-np and anti-ha antibody after infection of Pekin ducks with low pathogenic avian influenza virus

Original Article Evaluation of the kinetics of anti-np and anti-ha antibody after infection of Pekin ducks with low pathogenic avian influenza virus DOI: 1.12/vms3.18 Sylvie Marche, Thierry van den Berg

Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas

SUPPLEMENT ARTICLE Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas Eileen Thacker 1 and Bruce Janke 2 Departments of 1 Veterinary Microbiology

HPAI virus evolution and vaccination in Indonesia

OFFLU avian influenza virus characterisation meeting 29 30 March 2017 FAO Headquarters, Rome, Italy HPAI virus evolution and vaccination in Indonesia Ernes Andesfha 1 Hendra Wibawa 2,3 1 National Veterinary

Suggestions to prevent / control Respiratory Disease Complex in poultry

Suggestions to prevent / control Respiratory Disease Complex in poultry Dr. J. L. Vegad Adviser Phoenix Group 201/15, Gorakhpur, Jabalpur - 482001 Introduction Today, respiratory disease complex has emerged

JWPR Journal of World's Poultry Research

JWPR Journal of World's Poultry Research J. World's Poult. Res. 3(2): 38-42, 2013 2011, Scienceline Publication Sero-Virological studies on Newcastle Disease and Avian Influenza in Farmed Ostriches (Struthio

DURATION OF IMMUNITY OF LIVE VACCINE CEVAC S.

DURATION OF IMMUNITY OF LIVE VACCINE CEVAC S. Gallinarum TESTED BY Salmonella Enteritidis AND Salmonella Gallinarum CHALLENGES, 11 WEEKS AFTER VACCINATION József Herczeg1, Ágnes Makai1, Imre Héjja1, Éva

INFLUENZA-2 Avian Influenza

INFLUENZA-2 Avian Influenza VL 7 Dec. 9 th 2013 Mohammed El-Khateeb Overview 1. Background Information 2. Origin/History 3. Brief overview of genome structure 4. Geographical Distribution 5. Pandemic Nature